Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03982342 · ClinicalTrials.gov registry record · NA

Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants

A NA study, sponsored by Nationwide Children's Hospital.

Terminated
Registry status
NA
Development phase
1
Enrollment target

NCT03982342 is a NA study that was terminated before completion, run by Nationwide Children's Hospital. The registered enrollment target is 1 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03982342, a NA study, was terminated before completion, sponsored by Nationwide Children's Hospital.

TERMINATED
Registry status
NA
Development phase
1 participants
Enrollment target

Study Summary

This is a pilot study to collect preliminary data for a larger, multicenter clinical trial proposal. The study will examine two strategies commonly used to treat preterm infants diagnosed with a patent ductus arteriosus (PDA). The PDA closes after birth for most term infants, but in many preterm infants, it remains open (patent). A PDA may present a complication for a number of short-term problems faced by preterm infants. Longer-term issues include the development of pulmonary hypertension and changes in the size and performance of the heart. There is ongoing debate as to whether or not the PDA requires intervention.

Interventions

  • DEVICE Cather closure of patent ductus arteriosus (PDA)
  • OTHER Conservative management of patent ductus arteriosus (PDA)

Trial Details

FieldValue
Enrollment Target 1 participants
Start Date 2020-10-10
Est. Completion 2021-08-31
Phase NA

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT03982342

The ClinicalTrials.gov registry entry for NCT03982342 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Cather closure of patent ductus arteriosus (PDA) is the first listed.

NCT03982342 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03982342 about?

NCT03982342 is a clinical study titled "Preliminary Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low-weight Infants". This is a pilot study to collect preliminary data for a larger, multicenter clinical trial proposal. The study will examine two strategies commonly used to treat preterm infants diagnosed with a patent ductus arteriosus (PDA). The PDA closes after birth for most term infants, but in many preterm inf...

What is the current status of trial NCT03982342?

This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2020-10-10. Estimated completion is 2021-08-31.

What interventions are being tested in trial NCT03982342?

The interventions under investigation include: Cather closure of patent ductus arteriosus (PDA) (DEVICE), Conservative management of patent ductus arteriosus (PDA) (OTHER).

Who is sponsoring clinical trial NCT03982342?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.